Skip to main content
. 2022 Nov 18;51(2):254–266. doi: 10.1097/CCM.0000000000005736

TABLE 2.

Baseline Characteristics Among Included Studies

Study, Year Asfar et al (27) Lamontagne et al (28) Lamontagne et al (4)
Randomized Group Lower MAP Target Higher MAP Target Lower MAP Target Higher MAP Target Lower MAP Target Higher MAP Target
n 388 388 60 58 1,283 1,300
Baseline characteristics
 Age, yr 65 (15) 65 (13) 66 (13) 63 (13) 75.3 (6.6) 75.2 (6.9)
 Sex, male, n (%) 250 (64.4) 267 (68.8) 31 (51.7) 33 (56.9) 696 (57.2) 692 (55.9)
 Duration of vasopressor at randomization (min) 216 (126) 210 (132) 540 (180–960) 660 (300–1,020) 186 (102–277) (n = 1,247) 186 (104–284) (n = 1,262)
 Comorbidities
  Hypertension, n (%) 173 (44.6) 167 (43.0) 34 (56.7) 19 (32.8) 590 (46.0) 597 (46.0) (n = 1,299)
  Left ventricular failure, n (%) 53 (13.7) 59 (15.2) 4 (6.7) 6 (10.3) 143 (11.1) 143 (11.0) (n = 1,298)
 Cause(s) of vasodilatory hypotension, n (%) Sepsis, 388 (100) Sepsis, 388 (100) Sepsis, 46 (76.7) 37 (63.8) Sepsis, 953 (78.4) 964 (77.8)
Pancreatitis, 3 (5.0) 0 Not sepsis, 263 (21.6) 275 (22.2)
Overdose, 1 (1.7) 0 (n = 1,216) (n = 1,239)
Pulmonary embolism, 2 (3.3) 1 (1.7)
Burns, 1 (1.7) 2 (3.4)
Other, 7 (11.7)a 18 (31.0)b
 Illness severity
  Sequential Organ Failure Assessment 10.8 (3.1) 10.7 (3.1)
  Simplified Acute Physiology Score II score 57.2 (16.2) 56.1 (15.5)
  Acute Physiology and Chronic Health Evaluation II 24 (8) 25 (6) 20.9 (6.5) (n = 1,213) 20.6 (6.1) (n = 1,239)

MAP = mean arterial pressure.

a

Includes two patients in whom the admission diagnosis was unrelated to hypotension.

b

Includes 10 patients in whom the admission diagnosis was unrelated to hypotension.

Values are mean (sd) or median (interquartile range) as appropriate, unless otherwise specified. Dashes indicate data not reported.